InvestorsHub Logo
Followers 4
Posts 309
Boards Moderated 0
Alias Born 07/09/2018

Re: forever39 post# 10255

Monday, 09/12/2022 10:23:53 AM

Monday, September 12, 2022 10:23:53 AM

Post# of 10348
2.75 years after receiving 510(k) and publicly positioning AC5 to investors as a hemostat & sealant (Class III devices - would be illegal to promote AC5 as such to MD's), TN states that ARTH is now chasing podiatrists in the chronic wound care market. Another red herring to deflect investor lawsuits.